What is the claim deadline for the Eagle Pharma Securities Litigation Settlement?

The claim deadline is October 16, 2026. Filing is free and is done on the official settlement website at eaglepharmasecuritiessettlement.com.

Do I need proof of purchase for the Eagle Pharma Securities Litigation Settlement?

Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.

Is the Eagle Pharma Securities Litigation Settlement notice real, or a scam?

Claims are filed at eaglepharmasecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.

How long until I get paid from the Eagle Pharma Securities Litigation Settlement?

Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for August 19, 2026; no payments can be issued before a settlement receives final approval.

What happens if I do nothing?

You receive no payment, and in most class actions you also give up the right to sue Eagle Pharmaceuticals, Inc., et al. separately over these same claims. To keep that right you must opt out (exclude yourself) by July 29, 2026.

File by October 16, 2026securities

Eagle Pharma Securities Litigation Settlement

What happened

Eagle Pharmaceuticals, Inc. is the subject of a securities litigation class action. Shareholders who purchased the company's publicly traded common stock between August 9, 2022 and October 1, 2024 allege claims covered by this settlement, which the defendant has agreed to settle.

Do you qualify?

Anyone who purchased publicly traded common stock of Eagle Pharmaceuticals, Inc. between August 9, 2022 and October 1, 2024, inclusive.

How to file

Submit a Proof of Claim and Release form online or download a blank Claim Form from the Important Documents page and submit it by October 16, 2026. You must provide proof of your stock purchases during the class period to be eligible for payment.

Common questions

What is the claim deadline for the Eagle Pharma Securities Litigation Settlement?: The claim deadline is October 16, 2026. Filing is free and is done on the official settlement website at eaglepharmasecuritiessettlement.com.
Do I need proof of purchase for the Eagle Pharma Securities Litigation Settlement?: Yes. This settlement asks for documentation supporting your claim — a receipt, an account record, or the notice you were sent. Check the official settlement website for exactly which documents are accepted.
Is the Eagle Pharma Securities Litigation Settlement notice real, or a scam?: Claims are filed at eaglepharmasecuritiessettlement.com. Filing a class action claim is always free — no legitimate settlement charges you to claim, and no administrator will ask for payment, a gift card, or your full Social Security number by email or text. If a notice asks for any of those, it is not from the administrator. When in doubt, ignore the link you were sent and go to the official settlement website directly.
How long until I get paid from the Eagle Pharma Securities Litigation Settlement?: Class action payouts typically take 12 to 24 months after the claim deadline, and longer if the settlement is appealed. The final approval hearing for this case is set for August 19, 2026; no payments can be issued before a settlement receives final approval.
What happens if I do nothing?: You receive no payment, and in most class actions you also give up the right to sue Eagle Pharmaceuticals, Inc., et al. separately over these same claims. To keep that right you must opt out (exclude yourself) by July 29, 2026.

Who's involved

Plaintiffs

Joanna Pluta
Liyu Wang
NICHOLAS MILLER

Defendants

BRIAN CAHILL
SCOTT TARIFF
EAGLE PHARMACEUTICALS, INC.

Counsel for plaintiffs

JOSEPH COHENCOUNSEL NOT ADMITTED TO USDC - NJ BAR
JACK ZWICKCOUNSEL NOT ADMITTED TO USDC-NJ BAR
JAMES E. CECCHICARELLA BYRNE CECCHI BRODY & AGNELLO, P.C.
KEVIN G. COOPERCARELLA BYRNE CECCHI BRODY & AGNELLO

Counsel for defendants

MATTHEW JOSEPH CORRIELROPES & GRAY LLP
KOJI F. FUKUMURACOUNSEL NOT ADMITTED TO USDC - NJ BAR
BRIAN M. FRENCHCOUNSEL NOT ADMITTED TO USDC - NJ BAR
ALEXANDER LEE CALLOSAUL EWING LLP
SARAH ANN SULLIVANSAUL EWING LLP

Parties and counsel from the public court docket. Listing an attorney here isn't an endorsement, and ClaimWatch isn't affiliated with any of them.

New to class actions?

This summary was generated from public settlement documents and may contain errors. Confirm eligibility, deadlines, and payment terms on the official settlement website before filing. ClaimWatch is not a law firm and this is not legal advice. Filing a claim is free.

File a claim on the official site →

Claim deadline: October 16, 2026
Proof required: Yes
Class period: August 9, 2022 – October 1, 2024
Exclusion deadline: July 29, 2026
Final hearing: August 19, 2026
Case: Nicholas Miller v. Eagle Pharmaceuticals, Inc., et al.
Case number: 2:23-cv-23011-MAH
Court: U.S. District Court (District of New Jersey)

Official settlement website →

Case status & court docket

Federal court in New JerseyMore from New Jersey

U.S. District Court (District of New Jersey)

Active — filed December 11, 2023

April 10, 2026
Preliminary approval
TEXT ORDER: There will be a Virtual Hearing on the MOTION (Unopposed) for (I) Preliminary Approval of Class Action Settlement; (II) Certification of the Settlement Class; and (III) Approval of Notice of Settlement 62 on 5/18/2026 at 12:30 p.m. before the Undersigned. Counsel shall submit a tabbed co
March 26, 2026
Preliminary approval
Set Deadlines as to 62 MOTION (Unopposed) for (I) Preliminary Approval of Class Action Settlement; (II) Certification of the Settlement Class; and (III) Approval of Notice of Settlement . Motion set for 4/20/2026 before Magistrate Judge Michael A. Hammer. Unless otherwise directed by the Court, this

View the full court docket on CourtListener →

More securities settlements

View all →

August 28, 2026securities

Revance Securities Settlement

Revance Therapeutics and its executives made material misrepresentations and omissions regarding the company's relationship with Teoxane SA and the tender offer and merger transaction with Crown Laboratories, Inc., allegedly violating federal securities laws. Defendants deny any wrongdoing or liability.

Not yet determinable; depends on number of valid claims submitted

September 24, 2026securities

Biogen Securities Litigation Settlement

Biogen Inc. investors have settled a securities litigation case for $18.9 million in cash. The settlement resolves claims related to purchases of Biogen common stock during the specified class period.

October 6, 2026securities

NJ Bureau of Securities Settlement with Credit Suisse

Credit Suisse allegedly violated New Jersey Securities Law by making materially false and misleading statements regarding RMBS trust certificates and engaging in fraudulent practices. On October 24, 2022, the court entered a consent order requiring Credit Suisse to pay $300 million in restitution to investors. Credit Suisse neither admitted nor denied the allegations.

October 7, 2026securities

Stitch Fix Securities Litigation Settlement

Stitch Fix, Inc. is settling a securities class action lawsuit without admitting wrongdoing. The Lead Plaintiffs alleged that Stitch Fix issued misleading statements about its business, and shareholders who purchased the stock during the class period suffered damages as a result.